FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2799294403> ?p ?o ?g. }

• W2799294403 endingPage "e000572" @default.
• W2799294403 startingPage "e000572" @default.
• W2799294403 abstract "Background Egypt is experiencing a hepatocellular cancer (HCC) epidemic due to widespread hepatitis C virus (HCV) transmission. The use of sofosbuvir-related therapies producing improved treatment success has permitted an updated, nationwide, HCV treatment programme with expanded coverage. This study simulated the multidecade impacts of the new treatment programme on hepatitis and HCC. Methods A Markov model of HCV infection and treatment analysed the HCV-related HCC epidemic between 2009 and 2050, using parameters based on peer-reviewed studies and expert opinion. Comparing the ‘new’ and ‘old’ scenarios, and with the old treatment programme being replaced or not by the new programme in 2015, the annual number, prevalence and incidence of HCC were simulated for representative Egypt populations including HCV-infected patients aged 15–59 years in 2008, healthy people aged 5–59 years in 2008 and 5-year-old children cohorts entering the population each year beginning in 2009. Averted HCC cases were calculated, and sensitivity analyses were performed. Results Compared with the old scenario, the estimated number, prevalence and incidence of future HCC cases in the new scenario would peak earlier and at lower levels in 2025 (~29 000), 2023 (~28/100 000) and 2022 (~14/100 000), respectively. The new treatment programme is estimated to avert ~956 000 HCC cases between 2015 and 2050. Discussion By reducing cancer cases and shortening the peak epidemic period, the new programme should substantially diminish the HCC epidemic across Egypt. Our timeline forecast for Egypt’s HCC epidemic, and evaluation of various disease and programme components, should be useful to other countries that are developing policies to address HCV-related liver cancer prevention." @default.
• W2799294403 created "2018-05-17" @default.
• W2799294403 creator A5001032083 @default.
• W2799294403 creator A5001172041 @default.
• W2799294403 creator A5002412618 @default.
• W2799294403 creator A5020240700 @default.
• W2799294403 creator A5024845572 @default.
• W2799294403 creator A5061350277 @default.
• W2799294403 creator A5064151828 @default.
• W2799294403 creator A5074198631 @default.
• W2799294403 date "2018-04-01" @default.
• W2799294403 modified "2023-10-16" @default.
• W2799294403 title "Forecasted impacts of a sofosbuvir-based national hepatitis C treatment programme on Egypt’s hepatocellular cancer epidemic: simulation of alternatives" @default.
• W2799294403 cites W1975471977 @default.
• W2799294403 cites W1983969325 @default.
• W2799294403 cites W1991597423 @default.
• W2799294403 cites W1998891209 @default.
• W2799294403 cites W2000307707 @default.
• W2799294403 cites W2015973082 @default.
• W2799294403 cites W2017232326 @default.
• W2799294403 cites W2026933790 @default.
• W2799294403 cites W2036599322 @default.
• W2799294403 cites W2052045757 @default.
• W2799294403 cites W2063049747 @default.
• W2799294403 cites W2068705922 @default.
• W2799294403 cites W2074143794 @default.
• W2799294403 cites W2078145079 @default.
• W2799294403 cites W2117115804 @default.
• W2799294403 cites W2121058076 @default.
• W2799294403 cites W2145623055 @default.
• W2799294403 cites W2516395986 @default.
• W2799294403 cites W2583841702 @default.
• W2799294403 cites W2761789646 @default.
• W2799294403 cites W2769703277 @default.
• W2799294403 cites W4300882633 @default.
• W2799294403 doi "https://doi.org/10.1136/bmjgh-2017-000572" @default.
• W2799294403 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5914708" @default.
• W2799294403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29707244" @default.
• W2799294403 hasPublicationYear "2018" @default.
• W2799294403 type Work @default.
• W2799294403 sameAs 2799294403 @default.
• W2799294403 citedByCount "7" @default.
• W2799294403 countsByYear W27992944032018 @default.
• W2799294403 countsByYear W27992944032019 @default.
• W2799294403 countsByYear W27992944032021 @default.
• W2799294403 countsByYear W27992944032022 @default.
• W2799294403 countsByYear W27992944032023 @default.
• W2799294403 crossrefType "journal-article" @default.
• W2799294403 hasAuthorship W2799294403A5001032083 @default.
• W2799294403 hasAuthorship W2799294403A5001172041 @default.
• W2799294403 hasAuthorship W2799294403A5002412618 @default.
• W2799294403 hasAuthorship W2799294403A5020240700 @default.
• W2799294403 hasAuthorship W2799294403A5024845572 @default.
• W2799294403 hasAuthorship W2799294403A5061350277 @default.
• W2799294403 hasAuthorship W2799294403A5064151828 @default.
• W2799294403 hasAuthorship W2799294403A5074198631 @default.
• W2799294403 hasBestOaLocation W27992944031 @default.
• W2799294403 hasConcept C119599485 @default.
• W2799294403 hasConcept C120665830 @default.
• W2799294403 hasConcept C121332964 @default.
• W2799294403 hasConcept C126322002 @default.
• W2799294403 hasConcept C127413603 @default.
• W2799294403 hasConcept C144024400 @default.
• W2799294403 hasConcept C149923435 @default.
• W2799294403 hasConcept C159047783 @default.
• W2799294403 hasConcept C2522874641 @default.
• W2799294403 hasConcept C2776231280 @default.
• W2799294403 hasConcept C2776408679 @default.
• W2799294403 hasConcept C2776455275 @default.
• W2799294403 hasConcept C2778019345 @default.
• W2799294403 hasConcept C2778390639 @default.
• W2799294403 hasConcept C2780040827 @default.
• W2799294403 hasConcept C2908647359 @default.
• W2799294403 hasConcept C61511704 @default.
• W2799294403 hasConcept C71924100 @default.
• W2799294403 hasConcept C761482 @default.
• W2799294403 hasConcept C99454951 @default.
• W2799294403 hasConceptScore W2799294403C119599485 @default.
• W2799294403 hasConceptScore W2799294403C120665830 @default.
• W2799294403 hasConceptScore W2799294403C121332964 @default.
• W2799294403 hasConceptScore W2799294403C126322002 @default.
• W2799294403 hasConceptScore W2799294403C127413603 @default.
• W2799294403 hasConceptScore W2799294403C144024400 @default.
• W2799294403 hasConceptScore W2799294403C149923435 @default.
• W2799294403 hasConceptScore W2799294403C159047783 @default.
• W2799294403 hasConceptScore W2799294403C2522874641 @default.
• W2799294403 hasConceptScore W2799294403C2776231280 @default.
• W2799294403 hasConceptScore W2799294403C2776408679 @default.
• W2799294403 hasConceptScore W2799294403C2776455275 @default.
• W2799294403 hasConceptScore W2799294403C2778019345 @default.
• W2799294403 hasConceptScore W2799294403C2778390639 @default.
• W2799294403 hasConceptScore W2799294403C2780040827 @default.
• W2799294403 hasConceptScore W2799294403C2908647359 @default.
• W2799294403 hasConceptScore W2799294403C61511704 @default.
• W2799294403 hasConceptScore W2799294403C71924100 @default.
• W2799294403 hasConceptScore W2799294403C761482 @default.
• W2799294403 hasConceptScore W2799294403C99454951 @default.
• W2799294403 hasIssue "2" @default.

• next